Cooper University Health Care earned an A+ credit rating from Fitch Ratings (Fitch), an award-winning credit rating agency. This follows two credit upgrades from S&P Global and Moody’s since 2022. This new credit rating represents a double, or two-level, upgrade over Cooper’s 2022 rating.
“This A+ rating marks a remarkable turnaround for Cooper University Health Care from near bankruptcy at the turn of the century to today’s strong financial position,” said George E. Read more.
In recognition of National Heart Month, the Cooper Innovation Center, in collaboration with the New Jersey Economic Development Agency, Johnson & Johnson and the Foundation for Health Advancement/FVCG/NJHF, will host a Cardiovascular and Thoracic Innovation Symposium from 1 to 3:30 p.m., Tuesday, February 27, 2024, featuring a panel of leading physician innovators who will share their inventive technologies to improve cardiovascular and thoracic care. Read more.
Cooper University Health Care has been recognized as a Surgical Quality Partner by the American College of Surgeons (ACS), highlighting the institution’s unwavering commitment to delivering the highest standards of surgical care.
“Our designation as an ACS Surgical Quality Partner underscores our dedication to adhering to the most rigorous standards in surgical quality,” said Francis R. Spitz, MD, FACS, Head, Division of General Surgery, Cooper University Health Care. Read more.
Cooper University Health Care trauma surgeon John Chovanes, DO, FACS, USA, was the recipient of the prestigious John P. Pryor, MD Distinguished Service Award in Military Casualty Care, presented at the 37th Eastern Association for the Surgery of Trauma (EAST) Annual Scientific Assembly last week in Orlando, Florida. The award recognizes EAST members who have distinguished themselves in the field of military casualty care. Read more.
Recently, former NFL star and TV personality Michael Strahan and his 19-year-old daughter revealed that she was diagnosed with and being treated for medulloblastoma, a type of brain cancer.
Medulloblastoma is an aggressive cancer that usually occurs in the 4th ventricle of the brain – the space where spinal fluid is produced and the route it travels between the brain and spinal column. Read more.
MD Anderson Cancer Center at Cooper patient, Barbara Raphael, recently received the New Jersey Commission on Cancer Research (NJCCR) Patient Advocacy Award after being nominated by her physician, Dr. Generosa Grana.
The NJCCR Patient Advocacy Award recognizes members in the community who work to support cancer patients, whether pushing for early detection, better treatment options, or support for cancer research. Previous award recipients include cancer survivors who have used their strength to continue the fight to defeat cancer long after treatment is done. Read more.
Cooper University Health Care’s Community and Population Health team received a $25,000 grant from the Zallie Community Foundation to address a number of food insecurity initiatives.
The Cooper Community and Population Health team, which oversees Cooper’s community outreach efforts, will use the funds of this grant to launch a series of educational programs to raise awareness about nutrition, meal planning, and food resource management for patients and community members. Read more.
Cooper University Health Care, through its Urban Health Institute (UHI), has been awarded a two-year, $280,000 grant from the Bristol Myers Squibb Foundation to enhance screening for social determinants of health (SDoH), drive connections to community-based organizations to increase the breadth and depth of resources available to patients, and provide workforce development around the care of marginalized individuals. This grant is part of an initiative known as the New Jersey Safety Net Innovation Program (NJ SNIP). Read more.
(CAMDEN, NJ) – Researchers at MD Anderson Cancer Center at Cooper are leading the way in new approaches to treating advanced melanoma using tumor infiltrating lymphocyte (TIL) therapy. Earlier this year, MD Anderson at Cooper became the first site in the world to offer and enroll a patient in TILVANCE-301, a new randomized Phase III clinical trial evaluating the efficacy of TIL therapy as a first line treatment versus pembrolizumab (current standard of immunotherapy care) for advanced melanoma. Read more.
(CAMDEN, NJ) – Graceann Endicott, director of Medical Education in the Department of Emergency Medicine at Cooper University Health Care, has received the prestigious Accreditation Council for Graduate Medical Education’s (ACGME) Debra L. Dooley GME Program Coordinator Excellence Award.
This year, Endicott was one of only five program coordinators in the nation to receive the Debra L. Dooley GME Program Coordinator Excellence Award. Read more.